Piqray 200 mg

PIQRAY 200 MG is a pharmaceutical kit containing Alpelisib, used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

PIQRAY 200 MG is primarily used in combination with other treatments for certain types of cancer. Alpelisib, the active ingredient, is often part of a regimen aimed at addressing specific genetic mutations. Patients typically use this medication under strict medical supervision to manage advanced stages of the disease.

Common effects of PIQRAY 200 MG may include gastrointestinal issues, skin reactions, and changes in blood sugar levels. Some users might experience fatigue or appetite changes. These effects can vary widely among individuals and should be discussed with a healthcare provider.

PIQRAY 200 MG should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to avoid missing doses. Patients should be monitored regularly for any adverse reactions.

PIQRAY 200 MG may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Always inform your healthcare provider about all medications you are taking to prevent potential interactions.